Pappas Peter G, Kauffman Carol A, Andes David, Benjamin Daniel K, Calandra Thierry F, Edwards John E, Filler Scott G, Fisher John F, Kullberg Bart-Jan, Ostrosky-Zeichner Luis, Reboli Annette C, Rex John H, Walsh Thomas J, Sobel Jack D
Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama 35294-0006, USA.
Clin Infect Dis. 2009 Mar 1;48(5):503-35. doi: 10.1086/596757.
Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by health care providers who care for patients who either have or are at risk of these infections. Since 2004, several new antifungal agents have become available, and several new studies have been published relating to the treatment of candidemia, other forms of invasive candidiasis, and mucosal disease, including oropharyngeal and esophageal candidiasis. There are also recent prospective data on the prevention of invasive candidiasis in high-risk neonates and adults and on the empiric treatment of suspected invasive candidiasis in adults. This new information is incorporated into this revised document.
美国传染病学会的一个专家小组制定了侵袭性念珠菌病和黏膜念珠菌病患者的管理指南。这些更新后的指南取代了2004年1月15日发表在《临床传染病》上的先前指南,供护理患有这些感染或有感染风险患者的医护人员使用。自2004年以来,有几种新的抗真菌药物可供使用,并且发表了几项关于念珠菌血症、其他形式的侵袭性念珠菌病以及黏膜疾病(包括口腔和食管念珠菌病)治疗的新研究。最近也有关于高危新生儿和成人侵袭性念珠菌病预防以及成人疑似侵袭性念珠菌病经验性治疗的前瞻性数据。这些新信息已纳入本修订文件。